Logo image of INVE

IDENTIV INC (INVE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:INVE - US45170X2053 - Common Stock

3.43 USD
0 (0%)
Last: 12/26/2025, 8:00:02 PM
Fundamental Rating

4

Taking everything into account, INVE scores 4 out of 10 in our fundamental rating. INVE was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for INVE as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, INVE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

INVE had negative earnings in the past year.
In the past year INVE has reported a negative cash flow from operations.
In multiple years INVE reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: INVE reported negative operating cash flow in multiple years.
INVE Yearly Net Income VS EBIT VS OCF VS FCFINVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of INVE (48.06%) is better than 99.19% of its industry peers.
Looking at the Return On Equity, with a value of 50.51%, INVE belongs to the top of the industry, outperforming 98.39% of the companies in the same industry.
Industry RankSector Rank
ROA 48.06%
ROE 50.51%
ROIC N/A
ROA(3y)12.53%
ROA(5y)6.04%
ROE(3y)12.26%
ROE(5y)3.86%
ROIC(3y)N/A
ROIC(5y)N/A
INVE Yearly ROA, ROE, ROICINVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

Looking at the Profit Margin, with a value of 314.18%, INVE belongs to the top of the industry, outperforming 99.19% of the companies in the same industry.
In the last couple of years the Profit Margin of INVE has grown nicely.
The Operating Margin and Gross Margin are not available for INVE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 314.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y732.24%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INVE Yearly Profit, Operating, Gross MarginsINVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

8

2. Health

2.1 Basic Checks

INVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
INVE has more shares outstanding than it did 1 year ago.
INVE has more shares outstanding than it did 5 years ago.
There is no outstanding debt for INVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INVE Yearly Shares OutstandingINVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
INVE Yearly Total Debt VS Total AssetsINVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

INVE has an Altman-Z score of 4.01. This indicates that INVE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.01, INVE is in the better half of the industry, outperforming 60.48% of the companies in the same industry.
There is no outstanding debt for INVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.01
ROIC/WACCN/A
WACC8.9%
INVE Yearly LT Debt VS Equity VS FCFINVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 21.70 indicates that INVE has no problem at all paying its short term obligations.
INVE has a better Current ratio (21.70) than 96.77% of its industry peers.
A Quick Ratio of 20.77 indicates that INVE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 20.77, INVE belongs to the top of the industry, outperforming 97.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 21.7
Quick Ratio 20.77
INVE Yearly Current Assets VS Current LiabilitesINVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.67% over the past year.
Measured over the past years, INVE shows a very strong growth in Earnings Per Share. The EPS has been growing by 438.90% on average per year.
INVE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.71%.
Measured over the past years, INVE shows a very negative growth in Revenue. The Revenue has been decreasing by -20.49% on average per year.
EPS 1Y (TTM)16.67%
EPS 3Y438.9%
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-38.71%
Revenue growth 3Y-36.46%
Revenue growth 5Y-20.49%
Sales Q2Q%-23.32%

3.2 Future

INVE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.20% yearly.
INVE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.86% yearly.
EPS Next Y17.57%
EPS Next 2Y13.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-56.13%
Revenue Next 2Y-29.96%
Revenue Next 3Y40.96%
Revenue Next 5Y30.86%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVE Yearly Revenue VS EstimatesINVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M
INVE Yearly EPS VS EstimatesINVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

INVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year INVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INVE Price Earnings VS Forward Price EarningsINVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INVE Per share dataINVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as INVE's earnings are expected to grow with 13.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.2%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for INVE!.
Industry RankSector Rank
Dividend Yield 0%

IDENTIV INC

NASDAQ:INVE (12/26/2025, 8:00:02 PM)

3.43

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)03-03 2026-03-03/amc
Inst Owners53.71%
Inst Owner Change-7.65%
Ins Owners0.81%
Ins Owner Change2.34%
Market Cap81.46M
Revenue(TTM)26.63M
Net Income(TTM)73.95M
Analysts82.22
Price Target5.44 (58.6%)
Short Float %1.13%
Short Ratio5.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.44%
Min EPS beat(2)-3.34%
Max EPS beat(2)14.22%
EPS beat(4)2
Avg EPS beat(4)-2.42%
Min EPS beat(4)-58.98%
Max EPS beat(4)38.44%
EPS beat(8)2
Avg EPS beat(8)-46.26%
EPS beat(12)4
Avg EPS beat(12)-37.73%
EPS beat(16)7
Avg EPS beat(16)-47.74%
Revenue beat(2)1
Avg Revenue beat(2)0.62%
Min Revenue beat(2)-3.11%
Max Revenue beat(2)4.36%
Revenue beat(4)3
Avg Revenue beat(4)4.05%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)7.63%
Revenue beat(8)3
Avg Revenue beat(8)-0.58%
Revenue beat(12)3
Avg Revenue beat(12)-2.25%
Revenue beat(16)4
Avg Revenue beat(16)-2.13%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)5.51%
EPS NY rev (3m)5.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.88%
Revenue NY rev (3m)1.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.46
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.76
Fwd EYN/A
FCF(TTM)-0.91
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS0.99
BVpS6.16
TBVpS6.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 48.06%
ROE 50.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 314.18%
GM N/A
FCFM N/A
ROA(3y)12.53%
ROA(5y)6.04%
ROE(3y)12.26%
ROE(5y)3.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y732.24%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 72.18%
Cap/Sales 7.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 21.7
Quick Ratio 20.77
Altman-Z 4.01
F-Score4
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)126.88%
Cap/Depr(5y)106.77%
Cap/Sales(3y)6.31%
Cap/Sales(5y)4.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y438.9%
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y17.57%
EPS Next 2Y13.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.71%
Revenue growth 3Y-36.46%
Revenue growth 5Y-20.49%
Sales Q2Q%-23.32%
Revenue Next Year-56.13%
Revenue Next 2Y-29.96%
Revenue Next 3Y40.96%
Revenue Next 5Y30.86%
EBIT growth 1Y-112.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.24%
EBIT Next 3Y45.38%
EBIT Next 5Y33.76%
FCF growth 1Y-45.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.95%
OCF growth 3YN/A
OCF growth 5YN/A

IDENTIV INC / INVE FAQ

Can you provide the ChartMill fundamental rating for IDENTIV INC?

ChartMill assigns a fundamental rating of 4 / 10 to INVE.


What is the valuation status for INVE stock?

ChartMill assigns a valuation rating of 0 / 10 to IDENTIV INC (INVE). This can be considered as Overvalued.


Can you provide the profitability details for IDENTIV INC?

IDENTIV INC (INVE) has a profitability rating of 3 / 10.


Can you provide the financial health for INVE stock?

The financial health rating of IDENTIV INC (INVE) is 8 / 10.